- Round ID
- FR-00211
- Stage
- Series B
- Round name
- Series B
- Amount
- $32.5M
Dated funding evidence
Enara Bio
Series B · $32.5M · 2024-10-01
Reported round$32.5MSeries B
- Disclosure date
- 2024-10-01
- Reported currency
- USD
- Companies House
- 10469748
- Evidence sources
- 2
Company
Enara BioCH 104697482024-10-01Series B$32.5M
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Pfizer Ventures, M Ventures
- Other investors
- RA Capital, Samsara BioCapital, SV Health Investors, The Francis Crick Institute
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.